Psylo is a pharmaceutical research and development firm specializing in advanced psychedelics; our objective is to create widely available drugs as enhanced alternatives to existing SSRI medications, utilizing psychedelic compounds as the foundation. We are constructing a series of innovative compounds with the primary aim of advancing top candidates into clinical trials.